Together with robust data-driven modeling, rethinking regulation and data use could push forward a notoriously challenging ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, received an up to $21M award to lead a project to develop next-generation models of drug toxicity to advance safer ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI)[1] models in drug development and in regulatory submissions titled, ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

Eli Lilly has developed artificial intelligence models that can help predict the behavior of potential drug candidates, based on the data the drugmaker has collected over the last two decades and at ...

The joint guidance was created to ensure drug developers employ best practices when using AI.

Google gave an update on how it is using AI to advance science and build products at its recent Check Up event. In a blog post, Google's chief health officer, Dr. Karen DeSalvo, said that since the ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...